Finerenone is a non-steroidal mineralocorticoid receptor antagonist indicated for the treatment of chronic kidney disease (CKD) associated with type 2 diabetes. It reduces inflammation and fibrosis in renal and cardiovascular tissues, thereby slowing disease progression and lowering the risk of cardiovascular events.
Reviews
There are no reviews yet.